stock · yahoo
Eisai Co., Ltd.
4523.T
$24.67
▼ 0.1 (-0.42%)
polled · warming up
Abajo encontrarás el precio en vivo de Eisai Co., Ltd. (4523.T), un gráfico de 1 año, 8 indicadores (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) y el modo de comparación. Puedes añadir a tu cartera, marcar como favorito o configurar alertas de precio.
Day
-0.42%
-16.00
Week
-4.64%
-185.00
Month
-18.96%
-889.00
Year
-5.05%
-202.00
- Prev close
- $24.77
- Volume
- $3.78K
- Market cap
- $6.96B
- Currency
- USD (native JPY)
Financials
- 52w high
- ¥5,349
- 52w low
- ¥3,719
- 52w change
- -6.05%
- Day high
- ¥3,856
- Day low
- ¥3,790
- P/E (TTM)
- 27.74
- Forward P/E
- 18.75
- PEG
- 26.43
- Price / Book
- 1.19
- Beta (5Y)
- -0.11
- Enterprise value
- 1.04T
- EV / Revenue
- 1.26
- EV / EBITDA
- 11.28
- EPS (TTM)
- ¥136.96
- Forward EPS
- ¥202.57
- Dividend yield
- 4.19%
- Dividend rate
- ¥160
- Payout ratio
- 116.98%
- Revenue (TTM)
- 825.38B
- EBITDA
- 92.42B
- Free cash flow
- -21.68B
- Total cash
- 245.42B
- Total debt
- 186.08B
- Debt / Equity
- 20.11
- Current ratio
- 2.24
- Quick ratio
- 1.39
- Profit margin
- 4.67%
- Gross margin
- 76.83%
- Return on assets
- 2.33%
- Return on equity
- 4.53%
- Shares outstanding
- 282.11M
- Float
- 281.16M
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Analyst & Risk
Consensus
Buy
Mean rating2.46 / 5
Analysts13
Next earnings2026-08-03
Buy 4Hold 8Strong sell 1
Analyst price target
¥4,715.39
Mean target · 13 analysts
+24.1%
upside
Low ¥3,500Now ¥3,799High ¥5,600
- Beta (vs S&P 500)
- -0.11
- very stable
- 52-week change
- -6.05%
- Debt / Equity
- 20.11
- very high leverage
- Current ratio
- 2.24
- Quick ratio
- 1.39
- ROE
- 4.53%
- ROA
- 2.33%
- PEG ratio
- 26.43
- richly valued
- EV / Revenue
- 1.26
- EV / EBITDA
- 11.28
- Revenue growth
- 9.10%
- EBITDA
- 92.42B
- Free cash flow
- -21.68B
- Total cash
- 245.42B
- Total debt
- 186.08B
- Insider holdings
- 6.00%
- Institutional
- 56.04%
Noticias recientes
- Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH TrialMarketBeat6m ago
- Uber reveals an unexpected problem behind the AI boomTheStreet7m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily8m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.9m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.11m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory13m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool13m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire14m ago
Discusión en vivo
Iniciar sesión to join the discussion.
- Aún no hay comentarios. Sé el primero.